Middle East and Africa Ophthalmology Devices Market Industry Trends and Forecast to 2026

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 OVERVIEW OF MIDDLE EAST & AFRICA OPHTHALMOLOGY DEVICES MARKET
• 1.4 CURRENCY AND PRICING
• 1.5 LIMITATION
• 1.6 MARKETS COVERED
• 1.7 KEY INSIGHTS

2 MARKET SEGMENTATION

• 2.1 MARKETS COVERED
• 2.2 YEARS CONSIDERED FOR THE STUDY
• 2.3 GEOGRAPHIC SCOPE
• 2.4 CURRENCY AND PRICING
• 2.5 RESEARCH METHODOLOGY
• 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
• 2.7 DBMR MARKET POSITION GRID
• 2.8 MARKET APPLICATION COVERAGE GRID
• 2.9 DBMR MARKET CHALLENGE MATRIX
• 2.10 DBMR VENDOR SHARE ANALYSIS
• 2.11 SECONDARY SOURCES
• 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

• 3.1 DRIVERS
  • 3.1.1 INCREASE IN NUMBER OF CONTACT LENS USERS
  • 3.1.2 ADVANCEMENTS IN TECHNOLOGY
  • 3.1.3 INCREASEING PREVALENCE OF EYE DISEASES
• 3.2 RESTRAINTS
  • 3.2.1 HIGH COST OF EQUIPMENTS AND SURGERY
  • 3.2.2 POOR REIMBURSEMENT PROCEDURE FOR OPHTHALMIC SURGERY
• 3.3 OPPORTUNITIES
  • 3.3.1 PROGRAMS AND INITIATIVES TO REDUCE BURDEN OF EYE DISEASES
  • 3.3.2 LOW ADOPTION OF PHACOEMULSIFICATIN AND PREMIUM IOLS IN DEVELOPING COUNTRIES
• 3.4 CHALLENGES
  • 3.4.1 LESS NUMBER OF SKILLED PROFESSIONALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 MIDDLE EAST & AFRICA OPTHALMOLOGY DEVICES MARKET, BY PRODUCT TYPE

• 6.1 OVERVIEW
• 6.2 VISION CARE DEVICES
• 6.3 DIAGNOSTIC & MONITORING DEVICES
  • 6.3.1 OPTICAL COHERENCE THERAPY
  • 6.3.2 OPHTHALMOLOGY ULTRASOUND IMAGING SYSTEM
    • 6.3.2.1 B-SCAN ULTRASOUNDS
    • 6.3.2.2 A-SCAN BIOMETERS
    • 6.3.2.3 UBM ULTRASOUNDS
    • 6.3.2.4 PACHYMETERS
  • 6.3.3 FUNDUS CAMERAS
  • 6.3.4 SLIT LAMPS
  • 6.3.5 KERATOMETERS
  • 6.3.6 WAVEFRONT ABBERROMETERS
  • 6.3.7 AUTOREFRACTORS
  • 6.3.8 PERIMETERS
  • 6.3.9 TONOMETERS
  • 6.3.10 CORNEAL TOPOGRAPHY
  • 6.3.11 RETINOSCOPES
  • 6.3.12 SPECULAR MICROSCOPES
  • 6.3.13 VISUAL FIELD ANALYZERS
  • 6.3.14 OPHTHALMOSOCPES
• 6.4 SURGERY DEVICES
  • 6.4.1 CATARACT SURGERY DEVICES
    • 6.4.1.1 INTRAOCULAR LENSES
    • 6.4.1.2 OPHTHALMIC VISCOELASTICITY DEVICES
    • 6.4.1.3 PHACOEMULSIFICATION DEVICES
    • 6.4.1.4 RETINOSCOPES
  • 6.4.2 REFRACTIVE SURGERY DEVICES
    • 6.4.2.1 FEMTOSECOND LASERS
    • 6.4.2.2 EXCIMER LASERS
    • 6.4.2.3 MICROKERATOMES
  • 6.4.3 GLAUCOMA SURGERY DEVICES
    • 6.4.3.1 GLAUCOMA DRAINAGE DEVICES
    • 6.4.3.2 LASERS
    • 6.4.3.3 STENTS AND IMPLANTS
  • 6.4.4 VITREORETINAL SURGERY DEVICES
    • 6.4.4.1 VITRECTOMY MACHINES AND PACKS
    • 6.4.4.2 PHOTOCOAGULATION LASERS
    • 6.4.4.3 LLLUMINATION DEVICES
    • 6.4.4.4 VETRIORETINAL ACCESSORIES

  7 MIDDLE EAST & AFRICA OPTHALMOLOGY DEVICES MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 VISION CARE
  • 7.3 OPHTHALMIC WOUNDCARE
  • 7.4 CATARACT SURGERY
  • 7.5 OCULOPLASTICS
  • 7.6 OTHERS

  8 MIDDLE EAST & AFRICA OPTHALMOLOGY DEVICES MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 DIAGNOSIS CLINICS
  • 8.4 FRANCHISE OPTICAL STORES
  • 8.5 EYE RESEARCH INSTITUTES
  • 8.6 GOVERNMENT AGENCIES
  • 8.7 ACADEMICS

  9 MIDDLE EAST & AFRICA OPHTHALMOLOGY DEVICES MARKET, BY GEOGRAPHY

  • 9.1 OVERVIEW
  • 9.2 MIDDLE EAST AFRICA
    • 9.2.1 SOUTH AFRICA
    • 9.2.2 REST OF MIDDLE EAST & AFRICA
    • 9.2.3 EGYPT
    • 9.2.4 SAUDI ARABIA
    • 9.2.5 UNITED ARAB EMIRATES
    • 9.2.6 ISRAEL

  10 MIDDLE EAST & AFRICA OPHTHALMOLOGY DEVICES MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

  11 COMPANY PROFILES

  • 11.1 ESSILOR
    • 11.1.1 COMPANY SNAPSHOT
    • 11.1.2 REVENUE ANALYSIS
    • 11.1.3 COMPANY SHARE ANALYSIS
    • 11.1.4 PRODUCT PORTFOLIO
    • 11.1.5 RECENT DEVELOPMENTS
  • 11.2 NOVARTIS AG
    • 11.2.1 COMPANY SNAPSHOT
    • 11.2.2 REVENUE ANALYSIS
    • 11.2.3 COMPANY SHARE ANALYSIS
    • 11.2.4 PRODUCT PORTFOLIO
    • 11.2.5 RECENT DEVELOPMENTS
  • 11.3 JOHNSON & JOHNSON SERVICES, INC.
    • 11.3.1 COMPANY SNAPSHOT
    • 11.3.2 REVENUE ANALYSIS(MEDICAL DEVICES SEGMENYT)
    • 11.3.3 COMPANY SHARE ANALYSIS
    • 11.3.4 PRODUCT PORTFOLIO
    • 11.3.5 RECENT DEVELOPMENTS
  • 11.4 BAUSH AND LOMB INCORPORATED
    • 11.4.1 COMPANY SNAPSHOT
    • 11.4.2 REVENUE ANALYSIS
    • 11.4.3 COMPANY SHARE ANALYSIS
    • 11.4.4 PRODUCT PORTFOLIO
    • 11.4.5 RECENT DEVELOPMENTS
  • 11.5 HOYA CORPORATION
    • 11.5.1 COMPANY SNAPSHOT
    • 11.5.2 REVENUE ANALYSIS
    • 11.5.3 COMPANY SHARE ANALYSIS
    • 11.5.4 PRODUCT PORTFOLIO
    • 11.5.5 RECENT DEVELOPMENTS
  • 11.6 ACUFOCUS, INC.
    • 11.6.1 COMPANY SNAPSHOT
    • 11.6.2 GEOGRAPHICAL PRESENCE
    • 11.6.3 PRODUCT PORTFOLIO
    • 11.6.4 RECENT DEVELOPMENTS
  • 11.7 CANON INC.
    • 11.7.1 COMPANY SNAPSHOT
    • 11.7.2 REVENUE ANALYSIS
    • 11.7.3 PRODUCT PORTFOLIO
    • 11.7.4 RECENT DEVELOPMENTS
  • 11.8 COOPERVISION
    • 11.8.1 COMPANY SNAPSHOT
    • 11.8.2 GEOGRAPHICAL PRESENCE
    • 11.8.3 PRODUCT PORTFOLIO
    • 11.8.4 RECENT DEVELOPMENTS
  • 11.9 HAAG-STREIT GROUP
    • 11.9.1 COMPANY SNAPSHOT
    • 11.9.2 GEOGRAPHICAL PRESENCE
    • 11.9.3 PRODUCT PORTFOLIO
    • 11.9.4 RECENT DEVELOPMENTS
  • 11.10 HEIDELBERG ENGINEERING GMBH
    • 11.10.1 COMPANY SNAPSHOT
    • 11.10.2 GEOGRAPHICAL PRESENCE
    • 11.10.3 PRODUCT PORTFOLIO
    • 11.10.4 RECENT DEVELOPMENTS
  • 11.11 MARCO
    • 11.11.1 COMPANY SNAPSHOT
    • 11.11.2 PRODUCT PORTFOLIO
    • 11.11.3 RECENT DEVELOPMENTS
  • 11.12 NIDEK CO., LTD.
    • 11.12.1 COMPANY SNAPSHOT
    • 11.12.2 GEOGRAPHICAL PRESENCE
    • 11.12.3 PRODUCT PORTFOLIO
    • 11.12.4 RECENT DEVELOPMENTS
  • 11.13 STAAR SURGICAL
    • 11.13.1 COMPANY SNAPSHOT
    • 11.13.2 REVENUE ANALYSIS
    • 11.13.3 PRODUCT PORTFOLIO
    • 11.13.4 RECENT DEVELOPMENTS
  • 11.14 TOPCON CORPORATION
    • 11.14.1 COMPANY SNAPSHOT
    • 11.14.2 REVENUE ANALYSIS
    • 11.14.3 PRODUCT PORTFOLIO
    • 11.14.4 RECENT DEVELOPMENTS
  • 11.15 CARL ZEISS AG
    • 11.15.1 COMPANY SNAPSHOT
    • 11.15.2 REVENUE ANALYSIS
    • 11.15.3 PRODUCT PORTFOLIO
    • 11.15.4 RECENT DEVELOPMENTS
  • 11.16 ZIEMER OPHTHALMIC SYSTEMS (SUBSIDIARY OF ZIEMER GROUP AG)
    • 11.16.1 COMPANY SNAPSHOT
    • 11.16.2 GEOGRAPHICAL PRESENCE
    • 11.16.3 PRODUCT PORTFOLIO
    • 11.16.4 RECENT DEVELOPMENT

  12 RELATED REPORTS